Article

Cholesterol drugs may lower risk of AMD

Birmingham, AL-A study conducted here at the University of Alabama found that people who take cholesterol-lowering statin drugs are about 50% less likely to have age-related macular degeneration (AMD) than those who do not take the drugs.

Related Videos
4 experts are featured in this series.
4 experts are featured in this series.
Related Content
Tenpoint Therapeutics and Visus Therapeutics complete merger, combining ophthalmic therapeutics portfolios
December 12th 2024

Tenpoint Therapeutics and Visus Therapeutics complete merger, combining ophthalmic therapeutics portfolios

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Enhancing precision in GA imaging
December 12th 2024

Enhancing precision in GA imaging

Robert Chang, MD, discusses the impact of large language models on glaucoma care and AI in ophthalmology
November 5th 2024

Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MD

Updates on EXG102 and EXG202 for wet AMD from Exegenesis Bio
December 11th 2024

Updates on EXG102 and EXG202 for wet AMD from Exegenesis Bio

Study: Fluoxetine improves visual acuity in adults with amblyopia
December 11th 2024

Study: Fluoxetine improves visual acuity in adults with amblyopia

© 2024 MJH Life Sciences

All rights reserved.